Home
Conditions
Hemic and Lymphatic Diseases

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,120 public trials 3,997 recruiting studies

Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Leukemia Adapted Protocol

NCT06928909

Conditions: Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Kamuzu Central Hospital Lilongwe, Malawi

View Trial Details

Recruiting

Early Life Exposures Among Children With Sickle Cell Disease

NCT05377372

Conditions: Adverse Childhood Experiences, Anemia, Anemia, Hemolytic, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

NCT07649525

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Frailty, +19 more
Locations: Bristol Haematology and Oncology Centre Bristol, United Kingdom

Eastbourne District General Hospital Eastbourne, United Kingdom

St James University Hospital Leeds, United Kingdom

The Clatterbridge Cancer Centre - Liverpool Liverpool, United Kingdom

View Trial Details

Recruiting

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT00501826

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

NCT06594445

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

NCT06340646

Conditions: Adenocarcinoma, Blood Protein Disorders, Carcinoma, +30 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT04659616

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States

View Trial Details

Recruiting

Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania

NCT06079918

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Muhimbili University of Health and Allied Sciences Dar es Salaam, Tanzania

View Trial Details

Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

NCT06580002

Conditions: Adnexal Diseases, Blood Protein Disorders, Brain Cancer, +104 more
Locations: Chao Family Comprehensive Cancer Center, University of California Irvine Orange, California, United States

View Trial Details

Recruiting

Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

NCT07133997

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Hemic and Lymphatic Diseases

Hemic and Lymphatic Diseases trial results

Related conditions